Christopher Cannon Shares A Study Showing No Benefit When Adding an Antiplatelet to Anticoagulant in Stroke with AF and Atherosclerosis
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, shared on LinkedIn:
”Small randomized trial showing no benefit, and increased bleeding when adding an antiplatelet to anticoagulant in those with stroke , atherosclerosis and AF.”
Read the full article in JAMA Neurology.
Article: Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis. A Randomized Clinical Trial
Authors: Shuhei Okazaki, Kanta Tanaka, Yukako Yazawa, Ryosuke Doijiri, Masatoshi Koga, Masafumi Ihara, Shiro Yamamoto, Kenji Kamiyama, Yuko Honda, Kazutaka Uchida, Takeshi Yoshimoto, Koko Asakura, Katsuhiro Omae, Kenta Tanaka, Hirotada Maeda, Haruko Yamamoto, Teruyuki Hirano, Kazunori Toyoda, Yasuyuki Iguchi, Teruo Noguchi, Yasushi Okada, Kazuo Kitagawa, Nobuyuki Sakai, Hiroshi Yamagami
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC